Tumor-infiltrating immune cells (CD45+ and 7-AAD-) were isolated from LL2 tumor-bearing mice of the SNAP treatment group (0.004 mg/kg) and control group (PBS containing 0.004% DMSO). The gene discussed is PTPRC; the disease is neoplasm.